<?xml version='1.0' encoding='UTF-8'?>
<extracted-tables-set><pmcid>7720576</pmcid><all-ids><article-id xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" pub-id-type="pmid">33287704</article-id><article-id xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" pub-id-type="pmc">7720576</article-id><article-id xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" pub-id-type="publisher-id">1203</article-id><article-id xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" pub-id-type="doi">10.1186/s10194-020-01203-5</article-id></all-ids><extracted-table><table-id>Tab1</table-id><table-label>Table 1</table-label><table-caption>Baseline characteristics of MwoA patients and healthy subjects</table-caption><original-table><table-wrap xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" id="Tab1"><label>Table 1</label><caption><p>Baseline characteristics of MwoA patients and healthy subjects</p></caption><table frame="hsides" rules="groups"><thead><tr><th>Characteristics</th><th>MwoA, <bold><italic>n</italic></bold> = 72</th><th>HS, <bold><italic>n</italic></bold> = 46</th><th><bold><italic>P</italic></bold> value*</th></tr></thead><tbody><tr><td><bold>Female n(%)</bold></td><td>57 (79.2%)</td><td>34 (79.1%)</td><td>0.907</td></tr><tr><td><bold>Age</bold> (y) <bold>Mean (95%CI)</bold></td><td>21.30 (20.89–21.73)</td><td>21.24 (20.98–21.50)</td><td>0.789</td></tr><tr><td><bold>Height</bold> (cm) <bold>Mean (95%CI)</bold></td><td>160.22 (158.49–161.96)</td><td>161.11 (158.49–161.96)</td><td>0.493</td></tr><tr><td><bold>Weight</bold> (kg) <bold>Mean (95%CI)</bold></td><td>52.49 (50.56–54.42)</td><td>51.13 (49.33–52.93)</td><td>0.335</td></tr><tr><td><bold>Duration</bold> (mo) <bold>Mean (95%CI)</bold></td><td>66.75 (32.19–101.31)</td><td>–</td><td>–</td></tr><tr><td><bold>Headache intensity Mean (95%CI)</bold></td><td>5.55 (4.41–6.69)</td><td>–</td><td>–</td></tr><tr><td><bold>Headache frequency Mean (95%CI)</bold></td><td>5.89 (2.62–9.16)</td><td>–</td><td>–</td></tr><tr><td><bold>SAS score Mean (95%CI)</bold></td><td>46.11 (37.17–55.06)</td><td>–</td><td>–</td></tr><tr><td><bold>SDS score Mean (95%CI)</bold></td><td>45.73 (35.51–55.95)</td><td>–</td><td>–</td></tr></tbody></table><table-wrap-foot><p><italic>HS</italic> healthy subjects, <italic>MwoA</italic> migraine without aura, <italic>SAS</italic> self-rating anxiety scale, <italic>SDS</italic> self-rating depression scale</p><p>*, χ<sup>2</sup> test was applied for gender comparison, two-sample t test was applied for the rest comparisions, between MwoA patients and healthy subjects</p></table-wrap-foot></table-wrap></original-table><transformed-table>Table 1<div xmlns="http://www.w3.org/1999/xhtml" class="caption">Baseline characteristics of MwoA patients and healthy subjects</div><div xmlns="http://www.w3.org/1999/xhtml" class="table"><table frame="hsides" rules="groups"><thead><tr><th>Characteristics</th><th>MwoA, n = 72</th><th>HS, n = 46</th><th>P value*</th></tr></thead><tbody><tr><td>Female n(%)</td><td>57 (79.2%)</td><td>34 (79.1%)</td><td>0.907</td></tr><tr><td>Age (y) Mean (95%CI)</td><td>21.30 (20.89–21.73)</td><td>21.24 (20.98–21.50)</td><td>0.789</td></tr><tr><td>Height (cm) Mean (95%CI)</td><td>160.22 (158.49–161.96)</td><td>161.11 (158.49–161.96)</td><td>0.493</td></tr><tr><td>Weight (kg) Mean (95%CI)</td><td>52.49 (50.56–54.42)</td><td>51.13 (49.33–52.93)</td><td>0.335</td></tr><tr><td>Duration (mo) Mean (95%CI)</td><td>66.75 (32.19–101.31)</td><td>–</td><td>–</td></tr><tr><td>Headache intensity Mean (95%CI)</td><td>5.55 (4.41–6.69)</td><td>–</td><td>–</td></tr><tr><td>Headache frequency Mean (95%CI)</td><td>5.89 (2.62–9.16)</td><td>–</td><td>–</td></tr><tr><td>SAS score Mean (95%CI)</td><td>46.11 (37.17–55.06)</td><td>–</td><td>–</td></tr><tr><td>SDS score Mean (95%CI)</td><td>45.73 (35.51–55.95)</td><td>–</td><td>–</td></tr></tbody></table></div>HS healthy subjects, MwoA migraine without aura, SAS self-rating anxiety scale, SDS self-rating depression scale*, χ2 test was applied for gender comparison, two-sample t test was applied for the rest comparisions, between MwoA patients and healthy subjects</transformed-table></extracted-table><extracted-table><table-id>Tab2</table-id><table-label>Table 2</table-label><table-caption>The VBM and Reho comparisons between MwoA patients and healthy subjects</table-caption><original-table><table-wrap xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" id="Tab2"><label>Table 2</label><caption><p>The VBM and Reho comparisons between MwoA patients and healthy subjects</p></caption><table frame="hsides" rules="groups"><thead><tr><th>Contrast</th><th>Voxels</th><th>Brain regions</th><th colspan="3">peak MNI (x, y, z)</th><th>Z score</th></tr></thead><tbody><tr><td colspan="7"><bold><italic>VBM comparison between MwoA patients and healthy subjects</italic></bold></td></tr><tr><td rowspan="2"> MwoA &lt; HS</td><td>1508</td><td><p>bilateral superior and inferior colliculus</p><p>/ PAG / LC / MRN</p></td><td>-8</td><td>−23</td><td>−9</td><td>Inf</td></tr><tr><td>109</td><td>bilateral dorsal pons medulla junction</td><td>3</td><td>−38</td><td>−44</td><td>6.78</td></tr><tr><td> MwoA &gt; HS</td><td colspan="6">No brain region above the threshold.</td></tr><tr><td colspan="7"><bold><italic>Reho comparison between MwoA patients and healthy subjects</italic></bold></td></tr><tr><td rowspan="3"> MwoA &lt; HS</td><td>95</td><td>right MOG</td><td>33</td><td>−75</td><td>27</td><td>6.79</td></tr><tr><td>12</td><td>right IOG</td><td>21</td><td>−72</td><td>36</td><td>5.14</td></tr><tr><td>36</td><td>left MOG</td><td>−30</td><td>−81</td><td>21</td><td>6.14</td></tr><tr><td> MwoA &gt; HS</td><td>11</td><td>bilateral MRN</td><td>6</td><td>−33</td><td>−24</td><td>4.93</td></tr></tbody></table><table-wrap-foot><p><italic>HS</italic> healthy subjects, <italic>Inf</italic> infinity, <italic>IOG</italic> inferior occipital gyrus, <italic>LC</italic> locus ceruleus, <italic>MNI</italic> Montreal Neurological Institute coordinate, <italic>MOG</italic> middle occipital gyrus, <italic>MwoA</italic> migraine without aura patient, <italic>MRN</italic> median raphe nuclei, <italic>Reho</italic> regional homogeneity, <italic>VBM</italic> voxel-based morphometry</p><p>A threshold of <italic>P</italic> &lt; 0.05 family wise error (FWE) correction at cluster level were applied for all comparisons. Z score infinity in this table means the probability of the VBM value in the peak MNI(x = − 8, y = −23, z = −9) of healthy subjects &gt; migraineurs is approximately 100%</p></table-wrap-foot></table-wrap></original-table><transformed-table>Table 2<div xmlns="http://www.w3.org/1999/xhtml" class="caption">The VBM and Reho comparisons between MwoA patients and healthy subjects</div><div xmlns="http://www.w3.org/1999/xhtml" class="table"><table frame="hsides" rules="groups"><thead><tr><th>Contrast</th><th>Voxels</th><th>Brain regions</th><th colspan="3">peak MNI (x, y, z)</th><th>Z score</th></tr></thead><tbody><tr><td colspan="7">VBM comparison between MwoA patients and healthy subjects</td></tr><tr><td rowspan="2"> MwoA &lt; HS</td><td>1508</td><td>bilateral superior and inferior colliculus/ PAG / LC / MRN</td><td>-8</td><td>−23</td><td>−9</td><td>Inf</td></tr><tr><td>109</td><td>bilateral dorsal pons medulla junction</td><td>3</td><td>−38</td><td>−44</td><td>6.78</td></tr><tr><td> MwoA &gt; HS</td><td colspan="6">No brain region above the threshold.</td></tr><tr><td colspan="7">Reho comparison between MwoA patients and healthy subjects</td></tr><tr><td rowspan="3"> MwoA &lt; HS</td><td>95</td><td>right MOG</td><td>33</td><td>−75</td><td>27</td><td>6.79</td></tr><tr><td>12</td><td>right IOG</td><td>21</td><td>−72</td><td>36</td><td>5.14</td></tr><tr><td>36</td><td>left MOG</td><td>−30</td><td>−81</td><td>21</td><td>6.14</td></tr><tr><td> MwoA &gt; HS</td><td>11</td><td>bilateral MRN</td><td>6</td><td>−33</td><td>−24</td><td>4.93</td></tr></tbody></table></div>HS healthy subjects, Inf infinity, IOG inferior occipital gyrus, LC locus ceruleus, MNI Montreal Neurological Institute coordinate, MOG middle occipital gyrus, MwoA migraine without aura patient, MRN median raphe nuclei, Reho regional homogeneity, VBM voxel-based morphometryA threshold of P &lt; 0.05 family wise error (FWE) correction at cluster level were applied for all comparisons. Z score infinity in this table means the probability of the VBM value in the peak MNI(x = − 8, y = −23, z = −9) of healthy subjects &gt; migraineurs is approximately 100%</transformed-table></extracted-table><extracted-table><table-id>Tab3</table-id><table-label>Table 3</table-label><table-caption>Altered median raphe nuclei functional connectivity in MwoA patients</table-caption><original-table><table-wrap xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" id="Tab3"><label>Table 3</label><caption><p>Altered median raphe nuclei functional connectivity in MwoA patients</p></caption><table frame="hsides" rules="groups"><thead><tr><th>Contrast</th><th>Voxels</th><th>Brain regions</th><th colspan="3">MNI (x, y, z)</th><th>Z score</th></tr></thead><tbody><tr><td colspan="7"><bold><italic>Median raphe nuclei FC comparison between MwoA patients and healthy subjects</italic></bold></td></tr><tr><td rowspan="2"> MwoA &gt; HS</td><td>28</td><td>bilateral PAG</td><td>3</td><td>−21</td><td>−6</td><td>5.19</td></tr><tr><td>5</td><td>bilateral MRN</td><td>3</td><td>−30</td><td>− 24</td><td>5.18</td></tr><tr><td> MwoA &lt; HS</td><td colspan="6">No brain region above the threshold.</td></tr></tbody></table><table-wrap-foot><p><italic>HS</italic> healthy subjects, <italic>MNI</italic> Montreal Neurological Institute coordinate, <italic>MwoA</italic> migraine without aura patient, <italic>MRN</italic> median raphe nuclei, <italic>PAG</italic> periaqueductal gray</p><p>A threshold of <italic>P</italic> &lt; 0.05 family wise error (FWE) correction at cluster level were applied for all comparisons</p></table-wrap-foot></table-wrap></original-table><transformed-table>Table 3<div xmlns="http://www.w3.org/1999/xhtml" class="caption">Altered median raphe nuclei functional connectivity in MwoA patients</div><div xmlns="http://www.w3.org/1999/xhtml" class="table"><table frame="hsides" rules="groups"><thead><tr><th>Contrast</th><th>Voxels</th><th>Brain regions</th><th colspan="3">MNI (x, y, z)</th><th>Z score</th></tr></thead><tbody><tr><td colspan="7">Median raphe nuclei FC comparison between MwoA patients and healthy subjects</td></tr><tr><td rowspan="2"> MwoA &gt; HS</td><td>28</td><td>bilateral PAG</td><td>3</td><td>−21</td><td>−6</td><td>5.19</td></tr><tr><td>5</td><td>bilateral MRN</td><td>3</td><td>−30</td><td>− 24</td><td>5.18</td></tr><tr><td> MwoA &lt; HS</td><td colspan="6">No brain region above the threshold.</td></tr></tbody></table></div>HS healthy subjects, MNI Montreal Neurological Institute coordinate, MwoA migraine without aura patient, MRN median raphe nuclei, PAG periaqueductal grayA threshold of P &lt; 0.05 family wise error (FWE) correction at cluster level were applied for all comparisons</transformed-table></extracted-table></extracted-tables-set>